“Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s333. Accessed May 27, 2026. https://skin.dermsquared.com/skin/article/view/2550.